David Geffen School of Medicine at UCLA Hematology and Oncology Training Program  
Who We Are
Contact Us
Research Curriculum

Fellows in the UCLA Hematology-Oncology undertake research projects ranging from benchtop, basic science to investigator-initiated clinical trials and projects in public health and health care policy. There will be scheduled formal one-on-one meetings with the Fellowship Research Committee members in the fall of year 1 to review the process of finding and selecting a research area as well as prospective mentors. Research mentors are faculty within any division in the UCLA campus, as well as Jonnson Comprehensive Canter Center (JCCC), and Caltech.

During fellowship, some fellows additionally complete Masters of Science (MS) or Doctor of Philosophy (PhD) degrees through the STAR Program . Fellows interested in health policy research may also apply to the Robert Wood Johnson Clinical Scholars Program at UCLA to pursue a Masters of Science in Health Services. Research progress reports are given by all fellows in research at our Fall and Spring Research Retreats. Below is a representative list of recent fellows, their mentors, and research projects.




Sidharth Anand, MD

John Glaspy, MD

Improving the quality and efficiency of cancer care delivery – building a platform for continuous improvement

Amy Cummings, MD

Edward Garon, MD
Steven Dubinett, MD
Robert Elashoff, PhD

Human leukocyte antigen (HLA) B44 supertype and immunotherapy outcomes in non-small cell cancer

Kari Kubalanza, MD

Gottfried Konecny, MD

Predictive and prognostic markers of frontline preoperative chemotherapy and ovarian cancer: A retrospective analysis

Tasha Lin, MD

Yvonne Chen, MD

Engineering T-cells to overcome TGFb-mediated immunosuppression in the solid-tumor microenvironment

Zorawar Noor, MD

Edward Garon, MD
Matteo Pellegrini, PhD

Immune Monitoring in NSCLC Patients Treated with Immunotherapy

Caspian Oliai, MD

John Timmerman, MD

Preclinical studies of antibody-interferon-alpha fusion protein in B-cell malignancies

Steven Tsai, MD, PhD

Gay Crooks, MD

Identifying the first stages of hematopoietic commitment during human development

Maira Campos, MD

Gottfried Konecny, MD

Molecular stratification in Gynecologic Oncology as a strategy to improve treatment outcomes

Janai Carr, MD, PhD

Owen Witte, MD

Lessons in defining pre-metastatic cells in prostate cancer

Wanxing Chai-Ho, MD

John Chute, MD

The role of Grb10 in acute myeloid leukemia pathogenesis

Paul La Porte, MD, PhD

Mikhail Shapiro, PhD

Genetically engineered E. coli expressing gas vesicles in response to intestinal ischemia

Mykola Onyshchenko, MD, PhD

Antoni Ribas, MD, PhD

Understanding the mechanisms of PD-1 blockade resistance

John Shen, MD

Arash Naeim, MD, PhD

Sensing in at-risk populations

Find us on Facebook!